Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Physiologic endpoints (efficacy) for acute renal failure studies.

Patrick T Murray¹, Jean-Roger Le Gall, Dinis Dos Reis Miranda

¹Department of Medicine, University of Chicago, Chicago, Illinois, USA. pmurray@medicine.bsd.uchicago.edu

Current Opinion in Critical Care

|November 28, 2002

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.

Lancet (London, England)·2026

Same author

Cost-effectiveness of extracorporeal CPR for out-of-hospital cardiac arrest: a trial-based Markov model with a lifetime horizon.

European heart journal. Acute cardiovascular care·2026

Same author

Extracorporeal Life Support for Post-Cardiotomy Acute Right Ventricular Failure: A Retrospective Observational Multicenter Study.

The Annals of thoracic surgery·2026

Same author

Outcomes and prediction of mortality in patients requiring prolonged veno-arterial extracorporeal membrane oxygenation support in the PRECISE-ECLS observational study.

Critical care (London, England)·2026

Same author

Conversion From Venovenous to Venoarterial or Hybrid Extracorporeal Membrane Oxygenation: Analysis From the Extracorporeal Life Support Organization Registry.

Critical care medicine·2026

Same author

Increasing Anticoagulation Intensity in the Oxygenator During Flow Reduction Trials in Venoarterial Extracorporeal Membrane Oxygenation.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2025

Developing better physiologic surrogate endpoints is crucial for advancing acute renal failure research. This study proposes an approach to selecting effective endpoints for evaluating new therapies and improving patient outcomes.

Area of Science:

Nephrology
Clinical Trials
Biomarkers

Background:

Acute renal failure (ARF) research is hindered by a lack of validated physiologic surrogate endpoints.
Previous studies using urine output and serum/urine chemistries have failed to identify effective ARF interventions.
Phase II successes in ARF therapy have not translated to improved clinical outcomes in Phase III trials.

Purpose of the Study:

To address the critical need for suitable physiologic endpoints in ARF research.
To guide the selection of endpoints for testing novel ARF prevention and management strategies.
To improve the design and interpretation of clinical trials for acute kidney injury.

Main Methods:

Review of existing literature on ARF endpoints.

Related Experiment Videos

Analysis of candidate physiologic markers for efficacy studies.

Discussion of endpoints for both ARF prevention/management and renal replacement therapy.

Main Results:

Identified limitations of current surrogate endpoints in ARF clinical trials.
Proposed a framework for choosing appropriate physiologic endpoints.
Highlighted the importance of endpoints like glomerular filtration rate markers and renal blood flow.

Conclusions:

Effective physiologic endpoints are essential for validating new ARF therapies.
A systematic approach to endpoint selection can enhance the success of ARF clinical trials.
Improved endpoints will accelerate the development of interventions to reduce ARF morbidity and mortality.